KE
Kempen
Too few evaluable targets - at least 30 targets are required to show figures (28/30)
Development over time
Hit rate per year
–
20215 price targets
–
20222 price targets
–
20236 price targets
–
20241 price target
–
2025*14 price targets
* partial year: only targets at least 12 months old are counted
years with fewer than 30 targets are shown without a figure Read about the method
Evaluated price targets
targets at least 12 months old · newest first
- Camurus 2025-09-11 · 950 SEK ↑Missed
- Bavarian Nordic 2025-08-27 · 233 DKK ↓Hit after 19 days
- Cantargia 2025-08-27 · 8 SEK ↑Missed
- Egetis Therapeutics 2025-08-08 · 12 SEK ↑Missed
- Entra 2025-08-04 · 125 NOK ↓Hit after 14 days
- SLP 2025-07-14 · 44 SEK ↑Missed
- Catena 2025-07-14 · 500 SEK ↑Missed
- Zealand Pharma 2025-06-27 · 450 DKK ↑Hit after 68 days
- Gubra 2025-06-27 · 740 DKK ↑Missed
- Rockwool 2025-06-18 · 260 DKK ↓Hit after 63 days
- Wihlborgs 2025-04-24 · 120 SEK ↑Missed
- Castellum 2025-04-24 · 130 SEK ↑Missed
- Balder 2025-04-24 · 75 SEK ↑Missed
- Atrium Ljungberg 2025-01-15 · 210 SEK ↑Missed
- Balder 2024-01-10 · 70 SEK ↑Hit after 58 days
- Bioarctic 2023-11-27 · 350 SEK ↑Missed
- Wihlborgs 2023-04-06 · 80 SEK ↓Hit after 26 days
- SBB 2023-04-06 · 11 SEK ↓Hit after 27 days
- Hufvudstaden 2023-04-06 · 140 SEK ↑Hit after 5 days
- Fabege 2023-04-06 · 75 SEK ↓Hit after 33 days
Show more (8)
- Catena 2023-04-06 · 420 SEK ↑Hit after 64 days
- Catena 2022-11-04 · 420 SEK ↑Hit after 68 days
- Oncopeptides 2022-07-05 · 35 SEK ↑Hit after 15 days
- Calliditas 2021-12-16 · 320 SEK ↑Missed
- Kungsleden 2021-09-06 · 130 SEK ↑Hit after 74 days
- Hufvudstaden 2021-09-06 · 170 SEK ↑Missed
- Fabege 2021-09-06 · 170 SEK ↑Missed
- Castellum 2021-09-06 · 250 SEK ↑Hit after 73 days
The arrow shows the target's direction. Both upward and downward targets count as hits. Read about the method
Price targets from Kempen
Castellum (CAST)
Upside
+2.44%Target
130.00 SEKDate
Sep 4, 2026Wihlborgs (WIHL)
Upside
-7.89%Target
70.00 SEKDate
Sep 4, 2026Bioinvent (BINV)
Upside
+257.14%Target
80.00 SEKDate
May 28, 2026SLP (SLP-B)
Upside
+21.92%Target
42.00 SEKDate
Mar 30, 2026Sagax (SAGA-B)
Upside
+1.80%Target
170.00 SEKDate
Mar 30, 2026Hufvudstaden (HUFV-A)
Upside
+11.78%Target
130.00 SEKDate
Jan 13, 2026Balder (BALD-B)
Upside
+38.56%Target
70.00 SEKDate
Jan 13, 2026Atrium Ljungberg (ATRLJ-B)
Upside
+23.75%Target
31.00 SEKDate
Jan 13, 2026Camurus (CAMX)
Upside
+61.98%Target
950.00 SEKDate
Sep 11, 2025Cantargia (CANTA)
Upside
+409.55%Target
8.00 SEKDate
Aug 27, 2025Bavarian Nordic (BAVA)
Upside
+12.34%Target
233.00 SEKDate
Aug 27, 2025Egetis Therapeutics (EGTX)
Upside
+50.00%Target
12.00 SEKDate
Aug 8, 2025Entra (ENTRA)
Upside
+22.31%Target
125.00 SEKDate
Aug 4, 2025Catena (CATE)
Upside
+36.39%Target
500.00 SEKDate
Jul 14, 2025Gubra (GUBRA)
Upside
+144.87%Target
740.00 SEKDate
Jun 27, 2025Zealand Pharma (ZEAL)
Upside
+59.07%Target
450.00 SEKDate
Jun 27, 2025Rockwool (ROCK-B)
Upside
+40.69%Target
260.00 SEKDate
Jun 18, 2025Bioarctic (BIOA-B)
Upside
+7.83%Target
350.00 SEKDate
Nov 27, 2023Biovica (BIOVIC-B)
Upside
+9577.42%Target
30.00 SEKDate
Jun 16, 2023Fabege (FABG)
Upside
+7.68%Target
75.00 SEKDate
Apr 6, 2023SBB (SBB-B)
Upside
+274.15%Target
11.00 SEKDate
Apr 6, 2023Vicore Pharma (VICO)
Upside
+287.60%Target
40.00 SEKDate
Mar 29, 2023Oncopeptides (ONCO)
Upside
+1911.49%Target
35.00 SEKDate
Jul 5, 2022Calliditas (CALTX)
Upside
+53.85%Target
320.00 SEKDate
Dec 16, 2021Kungsleden (KLED)
Upside
+7.35%Target
130.00 SEKDate
Sep 6, 2021Synact Pharma (SYNACT)
Upside
+587.57%Target
125.00 SEKDate
Jun 28, 2021Xbrane Biopharma (XBRANE)
Upside
+1664.71%Target
180.00 SEKDate
Jun 2, 2021